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Summary: Mouse models have been generated to assess the roles of
selenoproteins involved with housekeeping tasks and/or stress-related phenomena in development and health. Each mouse model has taken advantage of
the fact that the synthesis of all seleno roteins is dependent on the expression
of two selenocysteine (Sec) ~RNA['=~] i s o f o m that differ fiom each other
by a single methyl group on the ribosyl moiety at position 34. The
population was selectively altered by generating
endogenous Sec
mouse models involving 1) transgenic animals carrying mutant or wild type
[ ~ ~ ~ 2)
~ conditional
~
knockout animals carrying a
Sec ~ R N A transgenes,
floxed Sec ~RNA'"']~~~
gene that was targeted for removal in specific tissues
and organs using loxP-Cre technology and 3) transgeniclstandard knockout
animals carrying mutant or wild type transgenes and a knockout of the Sec
~RNA[-]&~gene wherein the animal's survival is dependent on the
transgene. These mouse models perturbed selenoprotein expression, often in
a protein- and tissue-specific manner, permitting us to better assess their
function in health and development.

z

'RIis also affiliated with the Molecular Biology of Selenium Section, Laboratory of Cancer
Prevention, CCR, NCI, NIH, Bethesda, MD 20892.

Selenium: Its molecular biology and role in human health
Introduction
Numerous human clinical trials examining the role of selenium in health
have been initiated recently, or have already been completed. Perhaps the
most famous of those studies that have been completed is that of Clark et a1
[I]. These investigators reported in 1996 that supplementing the diet with
200 micrograms of seleniumlday reduced the incidence of prostate and colon
cancers by more than 50% and lung cancer by about 35%. This study
provided the basis for numerous subsequent human clinical trials involving
selenium. For example, the largest human clinical tial ever undertaken, the
Selenium and Vitamin E Cancer Prevention Trial (SELECT [2]), involves
more than 35,000 males in determining whether selenium and vitamin E may
play a role in protecting men against prostate cancer. Another human clinical
trial recently undertaken involves 1960 individuals in determining whether
selenium may have a role in preventing the occurrence of secondary lung
tumors in patients with a previous surgically removed non-small cell lung
lesion [3]. These trials are being carried out at the cost of hundreds of
millions of dollars with little or no understanding of how selenium acts
metabolically to bring about potential health benefits. It is important
therefore to generate mouse models to determine how selenium acts at the
molecular level in promoting better health and to determine whether small
molecular weight selenocompounds andlor selenoproteins are the responsible
agents.
Selenoproteins are dependent on Sec ~RNA['"]~' for their expression as
discussed in detail in Chapter 3 (see also [4,5]). In addition, the Sec
~ R N A population
[ ~ ~ ~ in~ mammalian
~ ~ ~
cells is composed of two major
isoforms that differ from each other by a 2'-0-methylribosyl moiety at
position 34 which is designated Urn34 (Chapter 3 and [4,5]). The two
isoforms, designated mcmSu and mcm5um, have different roles in
selenoprotein synthesis wherein mcmSu appears to be largely responsible for
the expression of housekeeping selenoproteins and mcmSum largely
responsible for selenoproteins involved in stress-related phenomena [6,7].
By perturbing the expression of Sec t w S " I S e cin mice, selenoprotein
synthesis can be altered in such a way that their roles in development and
I ~ ~ ~can~ be~
health can be readily studied. In fact, Sec ~ R N A synthesis
modulated in various ways in generating different mouse lines so that the
roles of selenoproteins involved in housekeeping tasks and in stress-related
phenomena can be elucidated. We have generated several mouse models for
examining the role of selenoproteins in development and health. These
mouse models involve generating transgenic, standard knockout, conditional
knockout or a combination of transgenic/knockout mice encoding either wild
type or a mutant Sec ~RNA[~~]"'
gene or transgene. It should also be noted
that the characteristics and properties of a number of individual
selenoproteins have been examined, including being targeted for removal, to

~ ~
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assess their roles in health and development (see the Chapters in Part 11.
Selenium-containing proteins).

Mouse models for elucidating the role of selenoproteins in development
and health
To generate mouse models for elucidating selenoprotein function, we took
advantage of the fact that selenoprotein synthesis is dependent on the
~r ~mouse
~ ~ models
~ ~ . involve the introduction of a
presence of Sec ~ R N A [Ou
~]&~
transgene, designated trspt, or manipulation of the Sec ~ R N A [ ~ gene,
designated trsp and they are summarized as follows: 1) transgenic mice
carrying wild type or a mutant trspt [a]; 2) conditional knockout mice
carrying a floxed trsp that can be specifically targeted for removal using
loxP-Cre technology [9]; and 3) standard knockout/transgenic mice
containing trsp knockout, designated Atrsp, and carrying wild type or mutant
trsp transgenes in which the survival of the animal is dependent on the
transgene [6,7]. A fourth mouse model is also briefly discussed wherein
transgenic/conditional knockout mice carrying two transgenes, a Cre
transgene under control of a promoter targeted for a specific organ or tissue,
and a wild type or mutant trspt in addition to the targeted (floxed) trsp (B.A.
Carlson, M.E. Moustafa, R. Shrimali, M. Rao, N. Zhong, S. Wang, L.
Feigenbaum, B.J. Lee, V.N. Gladyshev and D.L. Hatfield, submitted). The
mouse models are shown in Table 1. They were prepared for assessing the
roles of selenoproteins in health and development as well as defining the
A ~ ~mcmSu
~ ~and~ mcm5um,
~ ~ in
roles of the two Sec ~ R N isoforms,
selenoprotein synthesis. Since the role of mcm5u, which is largely involved
in the expression of housekeeping selenoproteins, and of mcmSLJm,which is
largely involved in the expression of selenoproteins involved in stress-related
phenomena, has been discussed in Chapter 3 and detailed elsewhere [5-71,
the emphasis of the present chapter is on generating mouse models for
examining the roles of selenoproteins in health and development. It should
be noted that some of our mouse models may also be used to elucidate the
role of small molecular weight selenocompounds in disease prevention.
Transgenic mouse models
Transgenic mice are generated by introducing one or more copies of the wild
type or mutant trsp into the mouse genome. The resulting mice are then bred
to obtain a stable breeding population (i.e., mice that are homozygous for the
transgene). Mutations were made at either position 37 [8] or at postion 34 in
Sec ~ R N A for
I preparing
~ ~ ~ ~mutant
~ ~ transgenes. The base at position 37 in
~ ~ ~ ~
(i6A), while that at
the fully maturated ~ R N A is[ isopentenyladenosine
position 34 is mcmSu (see Chapter 3 or [4,5]). The base at position 37 was
changed to G (A37->G37) and that at position 34 to A (T34->A34).
Importantly, neither of these two, very different, mutant tRNAs contain
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Um34, the methyl group located at the 2'-hydroxylribose on mcmSu [lo].
An A in the wobble position of the anticodon in any tRNA is normally
is converted to
converted to I. About 65% of the A34 mutant Sec ~RNA[&']~"
I34 in mouse liver (B.A. Carlson, M.E. Moustafa, R. Shrimali, M. Rao, N.
Zhong, S. Wang, L. Feigenbaum, B.J. Lee, V.N. Gladyshev and D.L.
Hatfield, submitted)$and interestingly, the ACA and ICA anticodons in A34
Sec ~ R N A [ ~ 'decode
~ " ~ UGU and UGU, UGC (UGU and UGC are codons
for cysteine) and UGA (UGA is the codon for Sec), respectively.
Table 1. Mouse models and their uses.

Type
Transgenic

Genotypea

usesb

trsp'

Transgenic

G37trspt

Transgenic
Standard K O ~
Conditional KOd

A34trspt
Atrsp
Atrsp'

Transgenic1
standard
KOd
Transgenic1
conditional KOd
(liver)

trsptlAtrsp

Determine if Sec ~RNA[*~]*'is
limiting [8]
SPcrescue in standard KOd [6,7l
SPc replacement in targeted tissues
and organse
Rescue of SPsc in KOdmice
Replacement of SPs in conditional
K O mice
~
Roles in muscle adaptation [9]and
cancer risk in prostate," mammarye
gland and colon'
SPc replacement only
SPcrescue with trspt & trsptG37
KOd trsp in various tissues and
organs using promoters that are
tissue and organ specific
SPc rescue in KOd mice [6,7]

G37trsptlAtrsp
trsptl~trs#

Partial SPc rescue in KOd mice [6,7]
SPc replacement in liveI8

~3 7trsPtlAtrs$

SPc replacement in liveI8

"Genotype designations used for mouse models (see text).
%ses - the various uses of the mouse models with accompanying references (see also text).
"SP - selenoprotein(s).
d~~ - knockout.
"AM Diamond, personal communication.
/R Irons, BA Carlson, DL Hatfield, C Davis, submitted.
Carlson, ME Moustafa, R Shrimali, M Rao, N Zhong, S Wang, L Feigenbaum, BJ Lee,
.VNGladyshev and DL Hatfield, submitted.

Mouse models in health and development
Initially, the resulting transgenic mice encoding multiple copies of trspt and
G37trspt (see Table 1) were examined [8]. This study provided the first
example of transgenic mice engineered to contain functional tRNA
transgenes. The fact that over-expression of wild type Sec
due to
the extra copies of trspt did not appear to influence selenoprotein synthesis in
the or ans and tissues examined suggested that the levels of the Sec
tRNA['rlb isoforms were not limiting in protein synthesis (reviewed in
[4,5]). However, mice carrying G37trspt had a pronounced effect on
selenoprotein expression and the effect occurred in a protein- and tissuespecific manner [8]. The most and least affected selenoproteins were
glutathione peroxidase 1 (GPx1) and thioredoxin reductase 1 (TR I),
respectively, and the organs which manifested the most and least affect on
selenoprotein synthesis were liver and testes, respectively. The mutant Sec
~ R N A ' product
~ ] ~ ~from G37trspt lacked the
base modification and
[ ~ ~ is~such
~ ~a manner
~ ~
altered the levels of the two host Sec ~ R N Aisoforms
that the Um34 species was reduced and the mcmSu species was enriched. As
the amount of the mutant tRNA increased with increasing numbers of
transgenes, the amount of the Um34 species and the amount of some
selenoproteins, and in particular, GPxl also decreased. The correlation in
reduction of the Urn34 isoform and certain selenoproteins led us to propose
that the Um34 modification is responsible for the expression of several
selenoproteins that are involved in the lower echelon of selenoprotein
hierarchy expression [5-71. Interestingly, many of the selenoproteins that are
expressed in the lower echelon of selenoprotein hierarchy and are sensitive to
selenium status, such as GPxl , serve largely stress-related functions, while
those that are expressed in the upper echelon of selenoprotein hierarchy and
are less sensitive to selenium status, such as TR1, serve largely housekeeping
functions. Those members associated with stress-related phenomena are the
ones dependent on the Sec ~RNA[~"]" Um34 modification for their
expression (see also Chapter 3 and [5-71).
As shown in Table 1, the ~37trsp'mice have been used in several different
studies. The studies have shown that these mice, which are deficient in
selenoproteins involved in stress-related phenomena, have an enhanced 1)
skeletal muscle adaptation after synergist ablation and following exercise [9],
2) incidence of prostate malignancy when the mice also carry an oncogene
directed to this tissue (see legend to Table I), and 3) incidence of breast
malignancy when the mice also carry an oncogene directed to this tissue (see
legend to Table 1). In addition, we have observed that G37trspt mice a
significantly greater number of azoxymethane (A0M)-induced aberrant crypt
formations (preneoplastic lesions in the colon) than wild type mice (R Irons,
BA Carlson, DL Hatfield and CD Davis, submitted). Supplementing the diets
of the AOM treated G37trspt and wild type mice with 0.1 and 2.0 pglg
selenium significantly reduced the incidence of preneoplastic lesions in both
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mouse lines. These observations are the first to provide evidence that both
selenoproteins and low molecular weight selenocompounds play a role in the
cancer protective effects of selenium.
In another study involving Sec ~RNA[*~]"mutant transgenic mice, we
examined the effect of A34trspt, which also lacked Um34, on selenoprotein
synthesis (B.A. Carlson, M.E. Moustafa, R. Shrirnali, M. Rao, N. Zhong, S.
Wang, L. Feigenbaum, B.J. Lee, V.N. Gladyshev and D.L. Hatfield,
submitted). The effects of A34trspt on down regulating stress-related
selenoprotein expression were similar to those of ~37trsp'.Since both these
mutants lack Um34, these observations provided further evidence that Um34
is responsible governing the expression of those selenoproteins involved in
stress-related phenomena.

Transgenic/knockout mouse models
Since the standard knockout of trsp is embryonic lethal [9,11], it appeared
that this mutant could not be used for further study of selenoprotein
expression. However, we devised a means of rescuing selenoprotein
expression by crossing heterozygous trsp knockout mice with homozygous
trspt transgenic mice and breeding the offspring to obtain a line of mice
lacking trsp (Atrsp) that was dependent on the trspt for survival [6,7]. One
advantage of rescuing a knockout mouse with a wild type or mutant
transgene is that the number of transgenes, and therefore, the levels of the
corresponding gene product can be maintained at normal or elevated amounts
depending on the transgene copy number. Rescuing with 20 copies of the
[ ~ ~ ~several
~ ~ fold,
~ but
wild type transgene enriched the Sec ~ R N Apopulation
little or no effect on selenoprotein expression in various tissues or organs
was observed [6,7]. These observations provided further evidence that Sec
~ R N A [ * ] is
~ not limiting in selenoprotein biosynthesis (reviewed in [4,5]).
Rescue of the Atrsp mice with the mutant transgene, ~37trsp'afforded us
with an opportunity of obtaining a mouse line with a mutant transgene
and selenoprotein
wherein there is no background of host Sec
expression is therefore totally dependent on the mutant tRNA. G37trsp
yielded a tRNA that lacked two base modifications, i6A37 and Urn34 (see
above, Chapter 3 and [6,10]) and mice rescued with G37trspt lacked several
selenoproteins including glutathione peroxidases 1 and 3, SelR and SelT
[6,7]. Interestingly, we were not successful in rescuing selenoprotein
synthesis in Atrsp mice with A34trspt (see reference to Carlson et a1 above).
As discussed in greater detail in Chapter 3, the novel regulation of several
selenoproteins involved in stress-related functions occurs at the level of
translation.
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Conditional knockout mouse models
Removal of trsp from the mouse genome is embryonic lethal [9,11] which
prevented fwrther study of the standard trsp knockout per se in selenoprotein
expression. We therefore prepared the conditional knockout of trsp using
loxP-Cre technology [9]. The removal of floxed trsp in mouse mammary
epithelium [9] and in liver hepatocytes [12] was examined. trsp was targeted
for removal in mammary epithelium using transgenic mice carrying the Cre
recombinase gene under the control of the mouse mammary tumor virus long
terminal repeat promoter or the whey acidic protein promoter. Neither Cre
promoter was effective in complete removal of trsp in mammary epithelial
cells, but the Sec
population was substantially reduced to alter
selenoprotein expression in a protein specific manner [9]. In liver, however,
the targeted removal of floxed trsp with transgenic mice carrying the Cre
recombinase under the control of the albumin promoter was virtually
complete [12]. Surprisingly, the mice survived without selenoprotein
expression in hepatocytes which comprise about 85% of the liver cell mass.
Selenoprotein P (SelP), which is the only known selenoprotein with multiple
Sec residues (see Chapters 9, 10 and 21), would seem to be largely made in
the liver and transported to other organs and tissues as its level was reduced
about 75% in plasma of the selenoproteinless liver knockout mice. These
mice appeared phenotypically normal until about 24 hours before death and
death appeared to be due to severe hepatocellular degeneration and necrosis
with concomitant necrosis of peritoneal and retroperitoneal fat [52].
Although most animals lacking selenoprotein expression in their liver died
within two to three months in this initial study, these animals may be kept
alive for extended periods of time on a diet enriched in other nutrients (U.
Schweizer, L. Schomburg and J. Kohrle, personal communication). This is
an important observation since these animals live much longer on a different
diet and can be subjected to various environmental agents to study the role of
selenoproteins in liver function and health.
As selenium has been implicated in heart disease (see Chapter 25) and
immune function (Chapter 27), we examined the role of selenoproteins in
cardiovascular disease and the immune system. By targeting the removal of
trsp in either endothelial cells or myocytes in skeletal and heart muscle, we
have elucidated the role of selenoproteins in cardiovascular disease (R.
Shrimali, J.A. Weaver, G.R. Miller, B.A. Carlson, S.V. Novoselov, E.
Kumaraswamy, V.N. Gladyshev and D.L. Hatfield, submitted). Removal of
selenoprotein expression in endothelial cells was embryonic lethal. 14.5-dayold embryos had numerous abnormalities including necrosis of the central
nervous system, subcutaneous hemorrhage and erythrocyte immaturity. Loss
of selenoprotein expression in myocytes, however, manifested no apparent
phenotype until about day 12 after birth, when affected mice developed
decreased mobility and an increased respiratory rate, followed by death
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within a few hours. Although there was no evidence of inflammation of the
skeletal muscle in mice that lacked trsp in myocytes, they had moderate to
severe myocarditis with inflammation extending into the mediastinum..
Targeted removal of trsp in endothelial cells demonstrated an essential role
of selenoproteins in their development, while targeted removal of trsp in
myocytes demonstrated an essential role of selenoproteins in proper function
of cardiac muscle. These studies also showed a direct connection between the
loss of selenoprotein expression and cardiovascular disease (R. Shrimali, J.A.
Weaver, G.R. Miller, B.A. Carlson, S.V. Novoselov, E. Kumaraswamy, V.N.
Gladyshev and D.L. Hatfield, submitted).
The conditional knockout of trsp is an important mouse model as it
provides a means of elucidating the roles of selenoproteins in health,
development and/or function in tissues or organs for which there is a specific
promoter. Promoters that function to express Cre early in development of a
specific tissue or organ can be used to assess the role of selenoproteins in
development of that tissue or organ. On the other hand, promoters that
function to express Cre after the tissue or organ is developed can be used to
assess the role of selenoproteins in proper function of that organ or tissue.
Furthermore, promoters that function to express Cre either early or late in
development of a specific tissue or organ, and provided the animal survives
for a long period of time following trsp knockout, can be used to examine the
animal's ability to handle various forms of stress (e.g., viral or bacterial
infection, carcinogen(s), cancer driver gene(s), etc). Those animals that
survive for long periods of time, while lacking selenoprotein expression in a
specific tissue or organ, can also be used to assess the role of small molecular
weight selenocompounds in health. Therefore, the conditional knockout of
trsp in specific tissues and organs is an important tool for assessing the role
of selenoproteins in health and development and this model can also be used
to assess the role of small molecular weight selenocompounds in protecting
the animal against environmental stresses.

Transgenic/conditional knockout mouse models
Although the rescue of mice encoding a Atrsp mice with G37trspt provides a
novel model for studying the role of housekeeping and stress-related
selenoproteins in health and the role of the two Sec ~ R N A [ ~isoforms
' ] ~ in
governing selenoprotein expression [6,7], this mouse model permit us to
focus on the animal as a whole and not on not on the roles of these
components in individual organs and tissues. However, removal of
selenoprotein expression by targeting floxed trsp with a specific promoter
Cre and replacing selenoprotein expression with a mutant trspt pemits us to
assess the role of housekeeping and stress-related selenoproteins, as well as
the role of both isoforms, in health andlor proper function of specific organs
or tissues. Selenoprotein removal was targeted in liver of the floxed trsp
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mouse using the albumin Cre promoter and selenoprotein expression was
replace with either G37trspt or A34trspt (B.A. Carlson, M.E. Moustafa, R.
Shrimali, M. Rao, N. Zhong, S. Wang, L. Feigenbaum, B.J. Lee, V.N.
Gladyshev and D.L. Hatfield, submitted). The pattern of replacing
selenoprotein expression, wherein several selenoproteins associated with
stress were not recovered, was similar with either the G37 and A34 mutant
]~'
govern
transgenes. The fact that the two mutant Sec ~ R N A ' ~ isoforms
selenoprotein expression in virtually an identical manner without the
[ ~ ~ ~ ~that
~ Urn34 is
influence of host wild type See ~ R N A demonstrates
responsible for the synthesis of stress-related selenoproteins.
Importantly, this mouse model will most certainly provide insights into one
of the central questions in the selenium field which is "What are the
contribution of selenoproteins versus low molecular weight
selenocompounds in the cancer chemopreventive effects of selenium and
other health benefits of this trace element?" Both these mutant transgenes
replaced housekeeping selenoprotein expression, but not stress-related
selenoprotein expression.
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